Skip to content
healthcare.dev

APHEXDA

NDC 73441-062, MOTIXAFORTIDE, injection, powder, lyophilized, for solution, from Gamida Cell Inc..

Product NDC
73441-062
Status
Listed
Labeler
Gamida Cell Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA217159
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73441-062 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MOTIXAFORTIDE ACETATE62 mg/1.7mL
Package NDCNDC-11Package
73441-062-01734410062011 VIAL, GLASS in 1 CARTON (73441-062-01) / 1.7 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e704b2db-f119-40ba-9346-9229e3281c9e
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=73441-062

Use it

Look up 73441-062 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73441-062 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73441-062. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.